Cepheid Gets Emergency Use Authorization for Rapid COVID Test
Cepheid received FDA EUA for a rapid molecular diagnostic test for qualitative detection of the virus that causes COVID-19.
Read MorePosted by Andy Lundin | May 13, 2022 | Covid 19, Rapid Assays |
Cepheid received FDA EUA for a rapid molecular diagnostic test for qualitative detection of the virus that causes COVID-19.
Read MorePosted by Andy Lundin | May 12, 2022 | Computing Systems, Covid 19, Rapid Assays |
The Center of BioModular Multi-Scale Systems for Precision Medicine creates rapid tests for human ailments like cancer, stroke, and COVID.
Read MorePosted by Andy Lundin | May 10, 2022 | Cancer, Company News |
Datar announced a contract with Artemis DNA, which provides Next Generation Sequencing genetic testing and diagnostic laboratory services.
Read MorePosted by Andy Lundin | May 9, 2022 | Molecular Diagnostic Analyzers |
A 384-well option is now available for Thermo Fisher Scientific’s Applied Biosystems QuantStudio 7 Pro Dx Real-Time PCR System.
Read MorePosted by Andy Lundin | May 6, 2022 | Covid 19, Rapid Assays |
A new study suggests continuous assessment and updating is likely needed in the context of variants of concern for rapid antigen COVID tests.
Read More